(Q40717466)
Statements
1 reference
A Phase III Study of Durvalumab (MEDI4736) With or Without Tremelimumab for Previously Treated Patients With Advanced NSCLC: Rationale and Protocol Design of the ARCTIC Study (English)
1 reference
David Planchard
1 reference
Takashi Yokoi
1 reference
Michael J McCleod
1 reference
Jürgen R Fischer
1 reference
Young-Chul Kim
1 reference
Marc Ballas
1 reference
Kelvin Shi
1 reference
17 March 2016
1 reference
1 reference
17
1 reference
3
1 reference
232-236.e1
1 reference
Identifiers
1 reference
1 reference